Cargando…

2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy

BACKGROUND: There are limited data reporting real-world incidence of integrase inhibitor resistance (INSTI-R) since the approval and first-line treatment recommendation of INSTIs in the US. A recent analysis of the national surveillance data estimated INSTI-R to be 6.3%. The purpose of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Januszka, Jenna, Drwiega, Emily N, Burgos, Rodrigo M, Michienzi, Sarah M, Smith, Renata, Badowski, Melissa E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752527/
http://dx.doi.org/10.1093/ofid/ofac492.1682